These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2840474)

  • 1. [Treatment of first-episode genital herpes with oral acyclovir].
    Kawana T; Hashido M
    Kansenshogaku Zasshi; 1988 Apr; 62(4):313-21. PubMed ID: 2840474
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological assessment of acyclovir treatment of herpes genitalis.
    Ragab NF; Habib MA; Ghozzi MY
    Arch Androl; 1989; 23(2):147-53. PubMed ID: 2556084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus.
    Ashley RL; Corey L
    J Clin Invest; 1984 Mar; 73(3):681-8. PubMed ID: 6323525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of acyclovir on antibody response to herpes simplex virus in primary genital herpetic infections.
    Bernstein DI; Lovett MA; Bryson YJ
    J Infect Dis; 1984 Jul; 150(1):7-13. PubMed ID: 6086772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir.
    Corey L; Mindel A; Fife KH; Sutherland S; Benedetti J; Adler MW
    Sex Transm Dis; 1985; 12(4):215-8. PubMed ID: 3001952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection.
    Mertz GJ; Critchlow CW; Benedetti J; Reichman RC; Dolin R; Connor J; Redfield DC; Savoia MC; Richman DD; Tyrrell DL
    JAMA; 1984 Sep; 252(9):1147-51. PubMed ID: 6088819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One year acyclovir suppression of frequently recurring genital herpes: a study of efficacy, safety, virus sensitivity and antibody response.
    Molin L; Ruhnek-Forsbeck M; Svennerholm B
    Scand J Infect Dis Suppl; 1991; 80():33-9. PubMed ID: 1666444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of combined treatment with oral and topical acyclovir in first episode genital herpes.
    Kinghorn GR; Abeywickreme I; Jeavons M; Barton I; Potter CW; Jones D; Hickmott E
    Genitourin Med; 1986 Jun; 62(3):186-8. PubMed ID: 3525386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal herpes simplex virus infection: relapse after initial therapy and transmission from a mother with an asymptomatic genital herpes infection and erythema multiforme.
    Brown ZA; Ashley R; Douglas J; Keilly M; Corey L
    Pediatr Infect Dis J; 1987 Nov; 6(11):1057-61. PubMed ID: 2827097
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic-dose acyclovir to suppress frequently recurring genital herpes simplex virus infection: effect on antibody response to herpes simplex virus type 2 proteins.
    Gold D; Ashley R; Solberg G; Abbo H; Corey L
    J Infect Dis; 1988 Dec; 158(6):1227-34. PubMed ID: 2848900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of HSV strains from patients with genital herpes treated with various formulations of acyclovir.
    Al-Hasani AM; Barton IG; Al-Omer LS; Kinghorn GR; Potter CW
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():113-9. PubMed ID: 3025151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical acyclovir in the treatment of genital herpes: a comparison with systemic therapy.
    Fiddian AP; Kinghorn GR; Goldmeier D; Rees E; Rodin P; Thin RN; de Konig GA
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():67-77. PubMed ID: 6355053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolonged treatment with acyclovir in recurrent genital herpes. Clinical, virological, and immunological response].
    Velasco M; Saavedra T; Sepúlveda C; Suárez M
    Rev Med Chil; 1991 Aug; 119(8):876-80. PubMed ID: 1668960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyclovir resistant genital herpes virus infection in a patient with AIDS.
    Marrero M; Alvarez M; Millan JC; Mas Lago P; Soler M; Diaz M
    Acta Virol; 1991 Jan; 35(1):86-9. PubMed ID: 1683121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Herpes genitalis].
    Petersen EE
    Gynakologe; 1985 Sep; 18(3):163-6. PubMed ID: 2997001
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status and prospects for oral acyclovir treatment of first episode and recurrent genital herpes simplex virus.
    Bryson YJ
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():61-5. PubMed ID: 6355052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic herpes simplex virus shedding from the genital tract whilst on suppressive doses of oral acyclovir.
    Bowman CA; Woolley PD; Herman S; Clarke J; Kinghorn GR
    Int J STD AIDS; 1990 May; 1(3):174-7. PubMed ID: 1964599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of systemic acyclovir treatment of genital HSV-2 infections on antibody responses to individual HSV-2 proteins.
    Ashley R; Mack K; Critchlow C; Shurtleff M; Corey L
    J Med Virol; 1988 Mar; 24(3):309-19. PubMed ID: 2835427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to herpes simplex virus glycoprotein D: effects of acyclovir and relation to recurrence.
    Bernstein DI; Stanberry LR; Harrison CJ; Shukla R; Kappes JC; Myers MG
    J Infect Dis; 1987 Sep; 156(3):423-9. PubMed ID: 3039009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyclovir therapy for genital herpes: enthusiasm and caution in equal doses.
    Whittington WL; Cates WJ
    JAMA; 1984 Apr; 251(16):2116-7. PubMed ID: 6538605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.